Skip to content

Opening book details…

About this Medicine article

Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) by Neubauer, Andreas; Wiesmann, Thomas; Vogelmeier, Claus F.; Mack, Elisabeth; Skevaki, Chrysanthi; Gaik, Christine; Keller, Christian; Figiel, Jens; Sohlbach, Kristina; Rolfes, Caroline; Renz, Harald; Wulf, Hinnerk; Burchert, Andreas is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Neubauer, Andreas; Wiesmann, Thomas; Vogelmeier, Claus F.; Mack, Elisabeth; Skevaki, Chrysanthi; Gaik, Christine; Keller, Christian; Figiel, Jens; Sohlbach, Kristina; Rolfes, Caroline; Renz, Harald; Wulf, Hinnerk; Burchert, Andreas
Publisher
Nature Publishing Group; Springer Science and Business Media LLC (ISSN 0887-6924)
Published
2020
Field
Medicine (Health Sciences)

More by Neubauer, Andreas; Wiesmann, Thomas; Vogelmeier, Claus F.; Mack, Elisabeth; Skevaki, Chrysanthi; Gaik, Christine; Keller, Christian; Figiel, Jens; Sohlbach, Kristina; Rolfes, Caroline; Renz, Harald; Wulf, Hinnerk; Burchert, Andreas

Browse all works by Neubauer, Andreas; Wiesmann, Thomas; Vogelmeier, Claus F.; Mack, Elisabeth; Skevaki, Chrysanthi; Gaik, Christine; Keller, Christian; Figiel, Jens; Sohlbach, Kristina; Rolfes, Caroline; Renz, Harald; Wulf, Hinnerk; Burchert, Andreas